1st Quarter - Report

BRYAN CAVE LEIGHTON PAISNER LLP for BIOTECHNOLOGY INDUSTRY ORGANIZATION

Period 1st Quarter 2010 Filed Apr 20, 2010 Signed by Julie Fleming, Reporting Specialist

Official filing
Firm
BRYAN CAVE LEIGHTON PAISNER LLP
Client
BIOTECHNOLOGY INDUSTRY ORGANIZATION
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Patent Reform Act of 2009- HR 1260, S 515, S610 Pathway for Biosimilars Act- HR 1548 Promoting Innovation and Access to Life-Saving medicine Act - HR 1427 The Affordable Health Care for America Act. HR 3962- general intelligence and contact regarding comparative effectiveness research America's Healthy Future Act of 2009. S. 1796-general intelligence and contact regarding importation

LobbyistCovered position, as disclosed
CYNTHIA E BERRY —
MATT JESSEE —
BRODERICK JOHNSON —
DAVID RUSSELL —
HARRY ANASTASIOS SPORIDIS —
JENNIFER STEWART —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1260 (111th), H.R. 1548 (111th), H.R. 3962 (111th), S. 1796 (111th), H.R. 1427 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.